Blog
RSS FeedPosted by Michael Wonder on 14 Apr 2021
PhRMA's three part approach to build a better health care system
13 April 2021 - Our plan is based on three key pillars: ending the pandemic and building a more resilient system, ...
Posted by Michael Wonder on 25 Mar 2021
Taxpayers fund research and drug companies make a fortune
24 March 2021 - The pharmaceutical industry doesn’t want things to change, but Americans can have both lower prices and innovation. ...
Posted by Michael Wonder on 09 Feb 2021
Collaboration between the FDA and industry is essential to foster innovation in Alzheimer’s treatments
8 February 2021 - As the Food and Drug Administration moves closer to a decision about whether to approve a ...
Posted by Michael Wonder on 13 Oct 2020
COVID-19 vaccines are chance at salvation, financial and beyond, for drug makers
13 October 2020 - Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts ...
Posted by Michael Wonder on 02 Oct 2020
Biotech industry pushes Trump Administration to release new vaccine guidelines
2 October 2020 - The BIO trade group, whose members include most of the vaccine makers, asked the health secretary to ...
Posted by Michael Wonder on 29 Sep 2020
Pfizer CEO on the pressures of creating a COVID-19 vaccine: ‘what is at stake is beyond imagination'
30 September 2020 - Albert Bourla, 58, is chairman and chief executive of Pfizer, a multinational pharmaceutical company. Bourla is a ...
Posted by Michael Wonder on 16 Sep 2020
Up is down — pharmaceutical industry caution versus federal acceleration of COVID-19 vaccine approval
15 September 2020 - Nine pharmaceutical company leaders took the unprecedented step on 8 September 2020, of stating that they would ...
Posted by Michael Wonder on 11 Aug 2020
Trump’s call for essential drugs to be made in US threatens innovation, says trade group
11 August 2020 - The trade group for the US pharmaceutical industry has warned that President Donald Trump’s latest executive ...
Posted by Michael Wonder on 22 Jul 2020
Coronavirus: pharmaceutical giants split on vaccine profits
22 July 2020 - Pharmaceutical companies are split on how they would price their potential COVID-19 vaccines, with some pledging ...
Posted by Michael Wonder on 20 Jul 2020
Many drug companies working on COVID-19 vaccines and treatments are lobbying harder than usual
20 July 2020 - Pharmaceutical companies racing to develop coronavirus treatments and vaccines have upped their lobbying presence in the ...
Posted by Michael Wonder on 16 Jul 2020
Deep dive into big pharma AI productivity: one study shaking the pharmaceutical industry
15 July 2020 - The pharmaceutical business is perhaps the only industry on the planet, where to get the product from ...
Posted by Michael Wonder on 06 Jul 2020
Pharma industry seizes on pandemic as a shot at redemption
6 July 2020 - It is almost five years since Hillary Clinton sent her $15 billion tweet. ...
Posted by Michael Wonder on 24 Jun 2020
Big pharma is taking big money from U.S. tax payers to find a coronavirus vaccine — and charge whatever they want for it
24 June 2020 - Congress must act now to ensure that COVID-19 vaccines and treatments are affordable. ...
Posted by Michael Wonder on 17 Jun 2020
An ‘America first’ pharma supply chain sounds good. But it won’t work.
17 June 2020 - With a stroke of the president’s Executive Order pen, the Trump administration awarded a $354 million, ...
Posted by Michael Wonder on 25 May 2020
Inside the science: companies racing to develop a COVID-19 vaccine
25 May 2020 - Even as some states move to ease the lockdowns that have cost tens of millions of ...